RAS oncogenes: the first 30 years
暂无分享,去创建一个
[1] M. Malumbres,et al. Mice deficient for N-ras: impaired antiviral immune response and T-cell function. , 2003, Cancer research.
[2] T. Bivona,et al. Ras pathway signaling on endomembranes. , 2003, Current opinion in cell biology.
[3] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[4] C. Der,et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. , 2002, Genes & development.
[5] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[6] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[7] H. Varmus,et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.
[8] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[9] M. Malumbres,et al. Targeted Genomic Disruption of H-ras and N-ras, Individually or in Combination, Reveals the Dispensability of Both Loci for Mouse Growth and Development , 2001, Molecular and Cellular Biology.
[10] Phillip T. Hawkins,et al. Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ , 2000, Cell.
[11] Kenji Nakamura,et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis , 2000, Oncogene.
[12] C. Der,et al. The Ras branch of small GTPases: Ras family members don't fall far from the tree. , 2000, Current opinion in cell biology.
[13] P. Hawkins,et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.
[14] L. Chin,et al. Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.
[15] W. Kabsch,et al. Guanosine triphosphatase stimulation of oncogenic Ras mutants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] John Kuriyan,et al. The structural basis of the activation of Ras by Sos , 1998, Nature.
[17] Lan Huang,et al. Structural basis for the interaction of Ras with RaIGDS , 1998, Nature Structural Biology.
[18] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[19] R. Kucherlapati,et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. , 1997, Genes & development.
[20] Jun Miyoshi,et al. K-Ras is essential for the development of the mouse embryo , 1997, Oncogene.
[21] Lan Huang,et al. Three-dimensional structure of the Ras-interacting domain of RalGDS , 1997, Nature Structural Biology.
[22] W. Kabsch,et al. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.
[23] T. Nagasu,et al. Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. , 1995, Cancer research.
[24] A. Kral,et al. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice , 1995, Nature Medicine.
[25] R. Kucherlapati,et al. The murine N-ras gene is not essential for growth and development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Bischoff,et al. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Fields,et al. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Demo,et al. ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.
[29] Michael J. Fry,et al. Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.
[30] A. Kazlauskas. Receptor tyrosine kinases and their targets. , 1994, Current opinion in genetics & development.
[31] P. Warne,et al. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro , 1993, Nature.
[32] S. Elledge,et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.
[33] Jonathan A. Cooper,et al. Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.
[34] M. Weber,et al. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. , 1993, Science.
[35] Paul W. Sternberg,et al. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation , 1993, Nature.
[36] F. McCormick. How receptors turn Ras on , 1993, Nature.
[37] F. McCormick. Signal transduction. How receptors turn Ras on. , 1993, Nature.
[38] T. Takenawa,et al. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[39] A. Ullrich,et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.
[40] Peng Li,et al. Identification of a mammalian gene structurally and functionally related to the CDC25 gene of Saccharomyces cerevisiae. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] B. Neel,et al. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21 , 1992, Nature.
[42] D. Bowtell,et al. Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. Martegani,et al. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. , 1992, The EMBO journal.
[44] H. Horvitz,et al. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains , 1992, Nature.
[45] P. Demoly,et al. [Transgenic mice]. , 1992, Annales de dermatologie et de venereologie.
[46] E. Lapetina,et al. Association of p21ras with phosphatidylinositol 3-kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] S H Kim,et al. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. , 1991, Journal of molecular biology.
[48] M. Wigler,et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.
[49] P. O’Connell,et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.
[50] W. Schafer,et al. Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein. , 1990, Science.
[51] Margaret Robertson,et al. The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.
[52] W. Kabsch,et al. Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules , 1990, Cell.
[53] R. Weinberg,et al. Identification of a nucleotide exchange-promoting activity for p21ras. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[54] B. Brownstein,et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.
[55] P. Casey,et al. Inhibition of purified p21 ras farnesyl:protein transferase by Cys-AAX tetrapeptides , 1990, Cell.
[56] Steven C. Almo,et al. Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis , 1990, Nature.
[57] A. Wolfman,et al. A cytosolic protein catalyzes the release of GDP from p21ras. , 1990, Science.
[58] W. Kabsch,et al. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation , 1989, Nature.
[59] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[60] W. Schafer,et al. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. , 1989, Science.
[61] C. Marshall,et al. All ras proteins are polyisoprenylated but only some are palmitoylated , 1989, Cell.
[62] G. A. Martin,et al. Molecular cloning of two types of GAP complementary DNA from human placenta. , 1988, Science.
[63] Irving S. Sigal,et al. Cloning of bovine GAP and its interaction with oncogenic ras p21 , 1988, Nature.
[64] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[65] S H Kim,et al. Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. , 1988, Science.
[66] F. McCormick,et al. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.
[67] S. Rodenhuis,et al. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.
[68] P. Leder,et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.
[69] R. Palmiter,et al. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice , 1987, Cell.
[70] M. Wigler,et al. The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway , 1987, Cell.
[71] L. C. Robinson,et al. CDC25: a component of the RAS-adenylate cyclase pathway in Saccharomyces cerevisiae. , 1987, Science.
[72] William E. Grizzle,et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis , 1987, Nature.
[73] B. Vogelstein,et al. Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.
[74] J. Miller,et al. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[75] Mark R. Smith,et al. Requirement for c-ras proteins during viral oncogene transformation , 1986, Nature.
[76] M. Wigler,et al. RAS proteins can induce meiosis in xenopus oocytes , 1985, Cell.
[77] P. Duesberg. Activated proto-onc genes: sufficient or necessary for cancer? , 1985, Science.
[78] M. Wigler,et al. In yeast, RAS proteins are controlling elements of adenylate cyclase , 1985, Cell.
[79] Mark R. Smith,et al. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells , 1985, Nature.
[80] M. Barbacid,et al. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats , 1985, Nature.
[81] J B Hurley,et al. Homologies between signal transducing G proteins and ras gene products. , 1984, Science.
[82] J. Feramisco,et al. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity , 1984, Nature.
[83] J B Gibbs,et al. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[84] D. Goeddel,et al. Comparative biochemical properties of normal and activated human ras p21 protein , 1984, Nature.
[85] D. Lowy,et al. The p21 ras C-terminus is required for transformation and membrane association , 1984, Nature.
[86] J. Feramisco,et al. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins , 1984, Nature.
[87] M. Barbacid,et al. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. , 1984, Science.
[88] Allan Balmain,et al. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas , 1984, Nature.
[89] A. Pellicer,et al. A molecular approach to leukemogenesis: mouse lymphomas contain an activated c-ras oncogene. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[90] R. Weinberg,et al. Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene , 1983, Molecular and cellular biology.
[91] M. Barbacid,et al. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations , 1983, Nature.
[92] R. Newbold,et al. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.
[93] H. Ruley. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture , 1983, Nature.
[94] Robert A. Weinberg,et al. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.
[95] C. Marshall,et al. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1 , 1983, Nature.
[96] A. Balmain,et al. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene , 1983, Nature.
[97] R. Muschel,et al. The human c-ras1H oncogene: a mutation in normal and neoplastic tissue from the same patient. , 1983, Science.
[98] M. Wigler,et al. Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[99] Kenji Shimizu,et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change , 1982, Nature.
[100] Eugenio Santos,et al. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene , 1982, Nature.
[101] Cori Bargmann,et al. Mechanism of activation of a human oncogene , 1982, Nature.
[102] M. Barbacid,et al. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes , 1982, Nature.
[103] R. Weinberg,et al. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene , 1982, Nature.
[104] C. Der,et al. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[105] M. Barbacid,et al. Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[106] R. Weinberg,et al. Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.
[107] M. Wigler,et al. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells , 1982, Nature.
[108] M. Wigler,et al. Human-tumor-derived cell lines contain common and different transforming genes , 1981, Cell.
[109] M. Gonda,et al. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes , 1981, Nature.
[110] N. Tsuchida,et al. Structure and Functions of the Kirsten Murine Sarcoma Virus Genome: Molecular Cloning of Biologically Active Kirsten Murine Sarcoma Virus DNA , 1981, Journal of virology.
[111] R. Weinberg,et al. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts , 1981, Nature.
[112] I. Pastan,et al. Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry , 1980, Cell.
[113] U. Rapp,et al. Generation of oncogenic mouse type C viruses: in vitro selection of carcinoma-inducing variants. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[114] R. Weinberg,et al. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[115] E. Scolnick,et al. Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[116] D. Lowy,et al. Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization , 1979, Journal of virology.
[117] E. Scolnick,et al. p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation , 1979, Journal of virology.
[118] E. Scolnick,et al. Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus. , 1979, Virology.
[119] M. Wigler,et al. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor , 1978, Cell.
[120] R. Huebner,et al. In vitro isolation of stable rat sarcoma viruses. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[121] E. Scolnick,et al. In vitro translation of Harvey murine sarcoma virus RNA , 1977, Journal of virology.
[122] R. Huebner,et al. Naturally occurring sarcoma virus of the BALB/cCr mouse. , 1974, Journal of the National Cancer Institute.
[123] E. Scolnick,et al. Studies on the Nucleic Acid Sequences of Kirsten Sarcoma Virus: a Model for Formation of a Mammalian RNA-Containing Sarcoma Virus , 1973, Journal of virology.
[124] W. Kirsten,et al. Morphologic responses to a murine erythroblastosis virus. , 1967, Journal of the National Cancer Institute.
[125] J. J. Harvey. An Unidentified Virus which causes the Rapid Production of Tumours in Mice , 1964, Nature.